Otonomy Announces OTIVIDEX™ Data Presentation at American Academy of Otolaryngology – Head and Neck Surgery Foundation Annual Meeting

Back to Jobs

Positive Results from AVERTS-2 Phase 3 Clinical Trial will Support Submission for U.S. Registration and Provide Basis for Ongoing Additional Phase 3 Trial SAN DIEGO , Oct. 02, 2018 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of

Apply Now